Poseida Therapeutics IncEigentümerstruktur
| Preis (2025-01-07) | 52W Hoch | 52W Tief |
| 9.5 USD | 0 USD | 0 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 9,5 USD | 0 | 0 | 5 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 97.466.704 | 5,08 | 1,49 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Poseida Therapeutics Inc
Mitarbeiter 350
Handelsplatz NASDAQ
Ticker Symbol PSTX
IPO Datum 2020-07-10
Adresse 9390 Towne Centre Drive, San Diego, CA, United States, 92121
Webseite https://poseida.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Mark J. Gergen J.D. | Executive Chairman of the Board |
| 2 | Ms. Johanna M. Mylet CPA | Chief Financial Officer |
| 3 | Mr. Loren Wagner | Chief Operations Officer |
| 4 | Ms. Kristin Martin | Chief People & Administration Officer |
| 5 | Mr. Alexander Chapman | Senior VP of Investor Relations & Corporate Communications |
| 6 | Mr. Harry J. Leonhardt Esq., J.D. | General Counsel, Chief Compliance Officer & Corporate Secretary |
| 7 | Dr. Devon J. Shedlock Ph.D. | Chief Scientific Officer of Cell Therapy |
| 8 | Ms. Lisa Portale | Senior Vice President of Regulatory Affairs |
| 9 | Dr. Jeffrey W. Winkelman J.D., Ph.D. | Senior VP & Chief Patent Counsel |
| 10 | Ms. Karen Basbaum M.B.A. | Senior Vice President of Business Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 2 | Pentwater Capital Management LP | 0,00% | 0,00 Mio. USD |
| 3 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 4 | Nomura Holdings Inc | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 6 | Eckert Corp | 0,00% | 0,00 Mio. USD |
| 7 | Boxer Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Boxer Capital LLC | 0,00% | 0,00 Mio. USD |
| 9 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 11 | Aisling Capital Management LP | 0,00% | 0,00 Mio. USD |
| 12 | SILVERARC CAPITAL MANAGEMENT, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Test Hedge Fund Mgmt | 0,00% | 0,00 Mio. USD |
| 14 | Charles Schwab Investment Management Inc | 0,00% | 0,00 Mio. USD |
| 15 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 16 | Glazer Capital, LLC | 0,00% | 0,00 Mio. USD |
| 17 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 18 | Highbridge Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 19 | Trium Capital LLP | 0,00% | 0,00 Mio. USD |
| 20 | 683 Capital Management LLC | 0,00% | 0,00 Mio. USD |